News tagged with methylphenidate

Stimulant treatment for ADHD not associated with increased risk of cardiac events in youth

Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food ...

Medicine & Health / Psychology & Psychiatry

created Feb 08, 2012 | popularity not rated yet | comments 0

Mechanism of calming hyperactivity by psychostimulant drugs identified

It has long been known that psychostimulant drugs have the paradoxical effect of reducing hyperactivity. [Psychostimulant drugs include methylphenidate – known by the trade names Ritalin, Concerta, and Methylin – ...

Medicine & Health / Psychology & Psychiatry

created Feb 07, 2012 | popularity 4 / 5 (1) | comments 0

Children with certain dopamine system gene variants respond better to ADHD drug

Children with certain dopamine system gene variants have an improved response to methylphenidate - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder - in a finding that could help eliminate ...

Medicine & Health / Psychology & Psychiatry

created Oct 21, 2011 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Prescribed stimulant use for ADHD continues to rise steadily

The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder (ADHD) rose slowly but steadily from 1996 to 2008, according to a study conducted by the National Institutes of Health (NIH) and ...

Medicine & Health / Psychology & Psychiatry

created Sep 28, 2011 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Common stimulant may speed recovery from general anesthesia

Administration of the commonly used stimulant drug methylphenidate (Ritalin) was able to speed recovery from general anesthesia in an animal study conducted at Massachusetts General Hospital (MGH). The report, appearing in ...

Medicine & Health / Other

created Sep 21, 2011 | popularity not rated yet | comments 0

Study suggests ADHD drugs may affect male puberty

(Medical Xpress) -- A new study released this week in the Proceedings of the National Academy of Science reveals that the medication methylphenidate, best known as Ritalin, may delay puberty in males. The researchers cautio ...

Medicine & Health / Medications

created Sep 20, 2011 | popularity 4.3 / 5 (3) | comments 0 | with audio podcast report

Time to address stimulant abuse on our campuses

Universities and colleges need to do more to protect young adults from the dangers of illicit stimulant use and to educate them about harms, argue the authors of an editorial in CMAJ (Canadian Medical Association Journal).

Medicine & Health / Health

created Sep 06, 2011 | popularity not rated yet | comments 0

Childhood cancer survivors show sustained benefit from common ADHD medication

A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter ...

Medicine & Health / Cancer

created Sep 13, 2010 | popularity not rated yet | comments 1

Ritalin improves brain function, task performance in cocaine abusers

(PhysOrg.com) -- Brain-scanning study shows Ritalin improves impaired brain function in people addicted to cocaine, implying it could play a role in facilitating recovery from addiction.

Medicine & Health / Research

created Sep 07, 2010 | popularity 4.8 / 5 (5) | comments 0 | with audio podcast

Attention deficit medication helps drug addicts: study

The active ingredient in Ritalin, a medication used to control the symptoms of attention deficit hyperactivity disorder, or ADHD, could help boost self-control in cocaine addicts, a study published Monday showed.

Medicine & Health / Medications

created Jul 26, 2010 | popularity 3.7 / 5 (3) | comments 3

Results from a study testing methylphenidate for cancer-related fatigue

Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently ...

Medicine & Health / Cancer

created Jun 02, 2010 | popularity not rated yet | comments 0

Research helps end guesswork in prescribing ADHD drug

Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate (MPH) than those without the genotype, according to new research from Cincinnati Children's Hospital Medical ...

Medicine & Health / Psychology & Psychiatry

created May 03, 2010 | popularity 5 / 5 (4) | comments 0

Behavioral incentives mimic effects of medication on brain systems in ADHD

Medication and behavioural interventions help children with Attention Deficit Hyperactivity Disorder (ADHD) better maintain attention and self control by normalising activity in the same brain systems, according to research ...

Medicine & Health / Psychology & Psychiatry

created Apr 01, 2010 | popularity 4.8 / 5 (4) | comments 0

Packages of care for ADHD in low- and middle-income countries

In the final article in a six part series on treating mental health problems in resource-poor settings, Alan Flisher, from the University of Cape Town, and colleagues present "packages of care" for treating Attention-Deficit/Hyperactivity ...

Medicine & Health / Psychology & Psychiatry

created Feb 23, 2010 | popularity not rated yet | comments 0

Attention drug drives memory research

(PhysOrg.com) -- Scientists at the Queensland Brain Institute have found a way to measure the attention span of a fly, which could lead to further advances in the understanding of attention-deficit hyperactivity disorder ...

Medicine & Health / Neuroscience

created Jan 20, 2010 | popularity 4.7 / 5 (3) | comments 0

Methylphenidate

Methylphenidate (Ritalin, MPH) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. It may also be prescribed for off-label use in treatment-resistant cases of lethargy, depression, neural insult and obesity. Methylphenidate belongs to the piperidine class of compounds and increases the levels of dopamine and norepinephrine in the brain through reuptake inhibition of the monoamine transporters. Methylphenidate possesses structural similarities to amphetamine and its pharmacological effects are more similar to those of cocaine, though MPH is less potent and longer in duration of action.

For more information about Methylphenidate, read the full article at Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.